SUMO2/3 Antikörper (AA 21-95)

Produktnummer ABIN1714011

Produktdetails anti-SUMO2/3 Antikörper

Target: SUMO2/3 (Small Ubiquitin Related Modifier 2/3 (SUMO2/3))

Bindungsspezifität: AA 21-95

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SUMO2/3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)

Kreuzreaktivität: Human

Homologie: Mouse,Rat,Cow,Horse,Chicken,Rabbit,Zebrafish

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Sumo 2+3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu SUMO2/3

Target: SUMO2/3 (Small Ubiquitin Related Modifier 2/3 (SUMO2/3))

Andere Bezeichnung: Sumo 2+3 (SUMO2/3 Produkte)

Synonyme: SUMO2 antikoerper, small ubiquitin-like modifier 2 antikoerper, SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae)-like antikoerper, small ubiquitin-related modifier 2 antikoerper, SUMO2 antikoerper, LOC711990 antikoerper, LOC714892 antikoerper

Hintergrund:

Synonyms: HSMT3, MGC117191, OTTHUMP00000115275, OTTHUMP00000115276, OTTHUMP00000115277, Sentrin 2, Small ubiquitin like modier 2, Small ubiquitin like modier protein 3, Small ubiquitin related modier 2, Small ubiquitin related modier 3, SMT3 A, SMT3 B, SMT3 H1, SMT3 H2, SMT3 homolog 1, SMT3 homolog 2, SMT3 homolog, SMT3 suppressor of m two 3 homolog 1, SMT3 suppressor of m two 3 homolog 2 S. cerevisiae, SMT3 suppressor of m two 3 homolog 2, SMT3 suppressor of m two 3 homolog 3 S. cerevisiae, SMT3 suppressor of m two 3 homolog 3, SMT3A, SMT3B, SMT3H1, SMT3H2, Sumo 2, Sumo 3, Sumo2, Sumo3, Suppressor of m two 3 homolog 2, Suppressor of m two 3 homolog 3, Ubiquitin like protein SMT3A, Ubiquitin like protein SMT3B, SUMO2_HUMAN, SUMO3_HUMAN.

Background: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2 and SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2, and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, SUMO-2 and SUMO-3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include IkBa, MDM2, p53, PML and Ran GAP1. SUMO-2 and SUMO-3 contribute to a greater percentage of protein modification than does SUMO-1, and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates b-Amyloid generation and may be critical in the onset or progression of Alzheimer?s disease.